Hadassah

Hadassah Medical Organization Names Prof. Zeev Rotstein as Director General Commencing January 2016

Wednesday, Nov 4 2015

MEDIA INQUIRES CONTACT:
Renee Young, National Public Relations
ryoung@hadassah.org
(212) 303- 8140

New York, NY - November 4, 2015 — Marcie Natan, National President of Hadassah, the Women’s Zionist Organization of America Inc., announced today that Prof. Zeev Rotstein will serve as the Director General of Hadassah Medical Organization (HMO) in Jerusalem, starting January 2016.

Prof. Zeev Rotstein has had a long and distinguished career at Chaim Sheba Medical Center in Tel Aviv where he began as a Senior Cardiologist in 1984 and has served as the Director General since 2004. Prof. Rotstein was also the Deputy Director of Sheba's Acute Care Hospital from 1988-1998 and its Director from 1998-2003.

Erez Meltzer, Chairman of the HMO Board of Directors, notes, "As a leader and physician, Prof. Zeev Rotstein is a perfect fit to guide HMO through the next stage of the Recovery Plan.  Prof. Rotstein’s combination of management experience, academic excellence, and care as a physician is crucial in addressing the challenges and nuances of Israel’s public health system and to continually improve HMO’s service to its patients."

Natan states, "I would like to thank Prof. Tamar Peretz for taking on the role of Interim Director General during a difficult period and for her contribution to the Hadassah Medical Organization. Hadassah has always prided itself on being the leading medical organization in Israel thanks to its outstanding hospital team. I have no doubt that under Prof. Rotstein’s guidance HMO will continue to be a leader in providing world class patient care and ground-breaking clinical research in Israel.  As HMO’s recovery continues, occupancy at Hadassah Ein Kerem is higher now than it has been over the past few years, and surgeries, deliveries and emergency room visits are exceeding 2014 totals."

###

Hadassah is the largest Jewish women’s organization in the United States. With 330,000 members, associates and supporters across the country, Hadassah brings Jewish women together to effect change and advocate on criticalissues such as medical care and research, women's empowerment, and the security of Israel. Through the Hadassah Medical Organization's (HMO) two hospitals, the world-renowned trauma center and the leading research facility in Jerusalem, Hadassah supports the delivery of exemplary patient care to over a million people every year. HMO serves without regard to race, religion or nationality and earned a Nobel Peace Prize Nomination in 2005 for building “bridges to peace” through equality in medical treatment. For more information, visit www.hadassah.org.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

READ MORE ›
alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More